Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CSVS, a crowdsourcing database of the Spanish population genetic variability

  • Peña-Chilet, María
  • The Spanish Exome Crowdsourcing Consortium
  • Dopazo, Joaquín
The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network., Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R, PT17/0009/0006 to J.D.; PI19/00321 and CIBERER ACCI-06/07/0036 to C.A., PI14-948, PI17-1659 and CIBERER ACCI-06/07/0036 to M.A.M.P.]; Regional Government of Madrid, RAREGenomics-CM [B2017/BMD-3721 to C.A. and B2017/BMD3721 to M.A.M.P.]; all co-funded with European Regional Development Funds (ERDF) as well as EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [676559]; University Chair UAM-IIS-FJD of Genomic Medicine and the Ramon Areces Foundation also supported this work. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A comparison of mechanistic signaling pathway activity analysis methods

  • Amadoz, Alicia
  • Hidalgo, Marta R.
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Understanding the aspects of cell functionality that account for disease mechanisms or drug modes of action is a main challenge for precision medicine. Classical gene-based approaches ignore the modular nature of most human traits, whereas conventional pathway enrichment approaches produce only illustrative results of limited practical utility. Recently, a family of new methods has emerged that change the focus from the whole pathways to the definition of elementary subpathways within them that have any mechanistic significance and to the study of their activities. Thus, mechanistic pathway activity (MPA) methods constitute a new paradigm that allows recoding poorly informative genomic measurements into cell activity quantitative values and relate them to phenotypes. Here we provide a review on the MPA methods available and explain their contribution to systems medicine approaches for addressing challenges in the diagnostic and treatment of complex diseases., This work was supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 from the ISCIII, both co-funded with European Regional Development Funds (ERDF), and EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 676559).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments

  • Çubuk, Cankut
  • Can, Fatma E.
  • Peña-Chilet, María
  • Dopazo, Joaquín
This article belongs to the Special Issue Targeting Signal Transduction Pathways and Non-coding RNAs as Potential Therapy in Cancer and Aging., Despite the existence of differences in gene expression across numerous genes between males and females having been known for a long time, these have been mostly ignored in many studies, including drug development and its therapeutic use. In fact, the consequences of such differences over the disease mechanisms or the drug action mechanisms are completely unknown. Here we applied mechanistic mathematical models of signaling activity to reveal the ultimate functional consequences that gender-specific gene expression activities have over cell functionality and fate. Moreover, we also used the mechanistic modeling framework to simulate the drug interventions and unravel how drug action mechanisms are affected by gender-specific differential gene expression. Interestingly, some cancers have many biological processes significantly affected by these gender-specific differences (e.g., bladder or head and neck carcinomas), while others (e.g., glioblastoma or rectum cancer) are almost insensitive to them. We found that many of these gender-specific differences affect cancer-specific pathways or in physiological signaling pathways, also involved in cancer origin and development. Finally, mechanistic models have the potential to be used for finding alternative therapeutic interventions on the pathways targeted by the drug, which lead to similar results compensating the downstream consequences of gender-specific differences in gene expression., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network "Machine Learning Frontiers in Precision Medicine" (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Platform to study intracellular polystyrene nanoplastic pollution and clinical outcomes

  • Bojic, Sanja
  • Falco, Matias M.
  • Stojkovic, Petra
  • Ljujic, Biljana
  • Gazdic Jankovic, Marina
  • Armstrong, Lyle
  • Markovic, Nebojsa
  • Dopazo, Joaquín
  • Lako, Majlinda
  • Bauer, Roman
  • Stojkovic, Miodrag
Increased pollution by plastics has become a serious global environmental problem, but the concerns for human health have been raised after reported presence of microplastics (MPs) and nanoplastics (NPs) in food and beverages. Unfortunately, few studies have investigate the potentially harmful effects of MPs/NPs on early human development and human health. Therefore, we used a new platform to study possible effects of polystyrene NPs (PSNPs) on the transcription profile of preimplantation human embryos and human induced pluripotent stem cells (hiPSCs). Two pluripotency genes, LEFTY1 and LEFTY2, which encode secreted ligands of the transforming growth factor‐beta, were downregulated, while CA4 and OCLM, which are related to eye development, were upregulated in both samples. The gene set enrichment analysis showed that the development of atrioventricular heart valves and the dysfunction of cellular components, including extracellular matrix, were significantly affected after exposure of hiPSCs to PSNPs. Finally, using the HiPathia method, which uncovers disease mechanisms and predicts clinical outcomes, we determined the APOC3 circuit, which is responsible for increased risk for ischemic cardiovascular disease. These results clearly demonstrate that better understanding of NPs bioactivities and its implications for human health is of extreme importance. Thus, the presented platform opens further aspects to study interactions between different environmental and intracellular pollutions with the aim to decipher the mechanism and origin of human diseases., Serbian Ministry of Education, Science and Technology, Grant/Award Number: ON175103; European Regional Development Funds; Spanish Ministry of Economy and Competitiveness, Grant/Award Number: SAF2017‐88908‐R; Engineering and Physical Sciences Research Council of the United Kingdom, Grant/Award Number: EP/S001433/1; ERC consolidator, Grant/Award Number: 614629.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SMN1 copy-number and sequence variant analysis from next-generation sequencing data

  • López-López, Daniel
  • Loucera, Carlos
  • Carmona, Rosario
  • Aquino, Virginia
  • Salgado-Garrido, Josefa
  • Pasalodos, Sara
  • Miranda, María
  • Alonso, Ángel
  • Dopazo, Joaquín
© 2020 The Authors., Spinal muscular atrophy (SMA) is a severe neuromuscular autosomal recessive disorder affecting 1/10,000 live births. Most SMA patients present homozygous deletion of SMN1, while the vast majority of SMA carriers present only a single SMN1 copy. The sequence similarity between SMN1 and SMN2, and the complexity of the SMN locus makes the estimation of the SMN1 copy-number by next-generation sequencing (NGS) very difficult. Here, we present SMAca, the first python tool to detect SMA carriers and estimate the absolute SMN1 copy-number using NGS data. Moreover, SMAca takes advantage of the knowledge of certain variants specific to SMN1 duplication to also identify silent carriers. This tool has been validated with a cohort of 326 samples from the Navarra 1000 Genomes Project (NAGEN1000). SMAca was developed with a focus on execution speed and easy installation. This combination makes it especially suitable to be integrated into production NGS pipelines. Source code and documentation are available at https://www.github.com/babelomics/SMAca., This study is supported by grants SAF2017‐88908‐R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de RecursosBiomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both cofunded with European Regional Development Funds as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (GA 813533) and “ELIXIR‐EXCELERATE fast‐track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

  • Loucera, Carlos
  • Esteban-Medina, Marina
  • Rian, Kinza
  • Falco, Matias M.
  • Dopazo, Joaquín
  • Peña-Chilet, María
Drug repurposing is a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case of emerging pathogens. In recent years, approaches based on network biology have demonstrated to be superior to genecentric ones.1 Here, we use an innovative methodology that combines mechanistic modeling of the signal transduction circuits related to SARS-CoV-2 infection (the COVID-19 disease map) with a machine-learning algorithm that learns potential causal interactions between proteins, already targets of drugs, and specific signaling circuits in the COVID-19 disease map, to suggest potentially repurposable drugs., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness, PT17/0009/0006, ACCI2018/29 from CIBER-ISCIII and COV20/00788 from the ISCIII, co-funded with European Regional Development Funds (ERDF), the grant “Large-scale drug repurposing in rare diseases by genomic Big Data analysis with machine learning methods” from the Fundación BBVA (G999088Q), as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A versatile workflow to integrate RNA-seq genomic and transcriptomic data into mechanistic models of signaling pathways

  • Garrido-Rodriguez, Martín
  • López-López, Daniel
  • Ortuño, Francisco M.
  • Peña-Chilet, María
  • Muñoz, Eduardo
  • Calzado, Marco A.
  • Dopazo, Joaquín
This is a PLOS Computational Biology Software paper., [Abstract] MIGNON is a workflow for the analysis of RNA-Seq experiments, which not only efficiently manages the estimation of gene expression levels from raw sequencing reads, but also calls genomic variants present in the transcripts analyzed. Moreover, this is the first workflow that provides a framework for the integration of transcriptomic and genomic data based on a mechanistic model of signaling pathway activities that allows a detailed biological interpretation of the results, including a comprehensive functional profiling of cell activity. MIGNON covers the whole process, from reads to signaling circuit activity estimations, using state-of-the-art tools, it is easy to use and it is deployable in different computational environments, allowing an optimized use of the resources available., [Author summary] Currently, RNA massive sequencing RNA-seq is the most extensively used technique for gene expression profiling in a single assay. The output of RNA-seq experiments contains millions of sequences, generated from cDNA libraries produced by the retro-transcription of RNA samples, that need to be processed by computational methods to be transformed into meaningful biological information. Thus, a number of bioinformatic workflows and pipelines have been proposed to produce different types of gene expression measurements, including in some cases, functional annotations to facilitate biological interpretation. While most pipelines focus exclusively on transcriptional data, the ultimate activity of the resulting gene product also depends critically on its integrity. Although traditional hybridization-based transcriptomics methodologies (microarrays) miss this information, RNA-seq data also contains information on variants present in the transcripts that can affect the function of the gene product, which is systematically ignored by current RNA-seq pipelines. MIGNON is the first workflow able to perform an integrative analysis of transcriptomic and genomic data in the proper functional context, provided by a mechanistic model of signaling pathway activity, making thus the most of the information contained in RNA-Seq data. MIGNON is easy to use and to deploy and may become a valuable asset in fields such as personalized medicine., JD has received these grants: SAF2017-88908-R from the Ministerio de Economía y Competitividad and PT17/0009/0006 from the Instituto de Salud Carlos III, as well as an FP7 People Marie-Curie Actions 813533 and and Horizon 2020 Framework Programme 676559., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CSVS, a crowdsourcing database of the Spanish population genetic variability

  • Peña-Chilet, María
  • Roldán, Gema
  • Pérez-Florido, Javier
  • Ortuño, Francisco M.
  • Carmona, Rosario
  • Aquino, Virginia
  • López-López, Daniel
  • Loucera, Carlos
  • Fernández-Rueda, José L.
  • Gallego, Asunción
  • García-García, Francisco
  • González-Neira, Anna
  • Pita, Guillermo
  • Núñez-Torres, Rocío
  • Santoyo-López, Javier
  • Ayuso, Carmen
  • Mínguez, Pablo
  • Ávila-Fernández, Almudena
  • Cortón, Marta
  • Moreno-Pelayo, Miguel Ángel
  • Morin, Matías
  • Gallego-Martinez, Álvaro
  • López-Escamez, José A.
  • Borrego, Salud
  • Antiñolo, Guillermo
  • Amigo, Jorge
  • Salgado-Garrido, Josefa
  • Pasalodos-Sánchez, Sara
  • Morte, Beatriz
  • Spanish Exome Crowdsourcing Consortium
  • Carracedo, Ángel
  • Alonso, Ángel
  • Dopazo, Joaquín
The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network. CSVS can be accessed at: http://csvs.babelomics.org/., Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R, PT17/0009/0006 to J.D.; PI19/00321 and CIBERER ACCI-06/07/0036 to C.A., PI14-948, PI17-1659 and CIBERER ACCI-06/07/0036 to M.A.M.P.]; Regional Government of Madrid, RAREGenomics-CM [B2017/BMD-3721 to C.A. and B2017/BMD3721 to M.A.M.P.]; all co-funded with European Regional Development Funds (ERDF) as well as EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [676559]; University Chair UAM-IIS-FJD of Genomic Medicine and the Ramon Areces Foundation also supported this work. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanistic modeling of the SARS-CoV-2 disease map

  • Rian, Kinza
  • Esteban-Medina, Marina
  • Hidalgo, Marta R.
  • Çubuk, Cankut
  • Falco, Matias M.
  • Loucera, Carlos
  • Gunyel, Devrim
  • Ostaszewski, Marek
  • Peña-Chilet, María
  • Dopazo, Joaquín
Here we present a web interface that implements a comprehensive mechanistic model of the SARS-CoV-2 disease map. In this framework, the detailed activity of the human signaling circuits related to the viral infection, covering from the entry and replication mechanisms to the downstream consequences as inflammation and antigenic response, can be inferred from gene expression experiments. Moreover, the effect of potential interventions, such as knock-downs, or drug effects (currently the system models the effect of more than 8000 DrugBank drugs) can be studied. This freely available tool not only provides an unprecedentedly detailed view of the mechanisms of viral invasion and the consequences in the cell but has also the potential of becoming an invaluable asset in the search for efficient antiviral treatments., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness, PT17/0009/0006, ACCI2018/29 from CIBER-ISCIII and COV20/00788 from the ISCIII, co-funded with European Regional Development Funds (ERDF), the grant “Large-scale drug repurposing in rare diseases by genomic Big Data analysis with machine learning methods” from the Fundación BBVA (G999088Q), as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genome-scale mechanistic modeling of signaling pathways made easy: A bioconductor/cytoscape/web server framework for the analysis of omic data

  • Rian, Kinza
  • Hidalgo, Marta R.
  • Çubuk, Cankut
  • Falco, Matias M.
  • Loucera, Carlos
  • Esteban-Medina, Marina
  • Alamo-Alvarez, Inmaculada
  • Peña-Chilet, María
  • Dopazo, Joaquín
Genome-scale mechanistic models of pathways are gaining importance for genomic data interpretation because they provide a natural link between genotype measurements (transcriptomics or genomics data) and the phenotype of the cell (its functional behavior). Moreover, mechanistic models can be used to predict the potential effect of interventions, including drug inhibitions. Here, we present the implementation of a mechanistic model of cell signaling for the interpretation of transcriptomic data as an R/Bioconductor package, a Cytoscape plugin and a web tool with enhanced functionality which includes building interpretable predictors, estimation of the effect of perturbations and assessment of the effect of mutations in complex scenarios., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and PT17/0009/0006 and PI20/01305 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559) to JD. Funding for open access charge: from the Spanish Ministry of Economy and Competitiveness / SAF2017-88908-R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Defective extracellular matrix remodeling in brown adipose tissue is associated with fibro-inflammation and reduced diet-induced thermogenesis

  • Pellegrinelli, Vanessa
  • Figueroa-Juárez, Elizabeth
  • Samuelson, Isabella
  • U-Din, Mueez
  • Rodríguez-Fdez, Sonia
  • Virtue, Samuel
  • Leggat, Jennifer
  • Çubuk, Cankut
  • Peirce, Vivian J.
  • Niemi, Tarja
  • Campbell, Mark
  • Rodríguez-Cuenca, Sergio
  • Dopazo, Joaquín
  • Carobbio, Stefania
  • Virtanen, Kirsi A.
  • Vidal-Puig, Antonio
© 2023 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)., The relevance of extracellular matrix (ECM) remodeling is reported in white adipose tissue (AT) and obesity-related dysfunctions, but little is known about the importance of ECM remodeling in brown AT (BAT) function. Here, we show that a time course of high-fat diet (HFD) feeding progressively impairs diet-induced thermogenesis concomitantly with the development of fibro-inflammation in BAT. Higher markers of fibro-inflammation are associated with lower cold-induced BAT activity in humans. Similarly, when mice are housed at thermoneutrality, inactivated BAT features fibro-inflammation. We validate the pathophysiological relevance of BAT ECM remodeling in response to temperature challenges and HFD using a model of a primary defect in the collagen turnover mediated by partial ablation of the Pepd prolidase. Pepd-heterozygous mice display exacerbated dysfunction and BAT fibro-inflammation at thermoneutrality and in HFD. Our findings show the relevance of ECM remodeling in BAT activation and provide a mechanism for BAT dysfunction in obesity., This work is supported by the Wellcome strategic award (100574/Z/12/Z); MRC MDU: MC_UU_12012/2 and MC_UU_12012/5 (The Disease Model Core, Biochemistry Assay Lab, Histology Core, and the Genomics and Transcriptomics Core); the Wellcome grant 10953/Z/15/Z (I.S.); the Wellcome Cambridge Trust scholarship (E.F.-J.); the Spanish Ministry of Economy and Competitiveness (SAF2017-88908-R) and PT17/0009/0006 from the ISCIII (C.Ç. and J.D.B.); the Academy of Finland (grants 259926, 265204, 292839, 314456, and 335446), the Paulo Foundation, the Finnish Cultural Foundation Southwest Finland Regional Fund, the Turku University Hospital Research Funds, and the European Union (EUFP7 project 278373; DIABAT) (K.A.V. and M.U.-D.); the Fundación Ramón Areces (BEVP32P01S10090) and subsequently by a Sir Henry Wellcome postdoctoral fellowship (222748/Z/21/Z) (S.R.-F.); We thank the Wellcome-Trust Sanger Institute Mouse Genetics Project (Sanger MGP) and its funders for providing the mutant mouse line (Pepd<tm1a[KOMP]Wtsi). Funding and associated primary phenotypic information may be found at www.sanger.ac.uk/mouseportal., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A comparison of mechanistic signaling pathway activity analysis methods

  • Amadoz, Alicia
  • Hidalgo, Marta R.
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Understanding the aspects of cell functionality that account for disease mechanisms or drug modes of action is a main challenge for precision medicine. Classical gene-based approaches ignore the modular nature of most human traits, whereas conventional pathway enrichment approaches produce only illustrative results of limited practical utility. Recently, a family of new methods has emerged that change the focus from the whole pathways to the definition of elementary subpathways within them that have any mechanistic significance and to the study of their activities. Thus, mechanistic pathway activity (MPA) methods constitute a new paradigm that allows recoding poorly informative genomic measurements into cell activity quantitative values and relate them to phenotypes. Here we provide a review on the MPA methods available and explain their contribution to systems medicine approaches for addressing challenges in the diagnostic and treatment of complex diseases., This work was supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 from the ISCIII, both co-funded with European Regional Development Funds (ERDF), and EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 676559).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CSVS, a crowdsourcing database of the Spanish population genetic variability

  • Peña-Chilet, María
  • The Spanish Exome Crowdsourcing Consortium
  • Dopazo, Joaquín
The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network., Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R, PT17/0009/0006 to J.D.; PI19/00321 and CIBERER ACCI-06/07/0036 to C.A., PI14-948, PI17-1659 and CIBERER ACCI-06/07/0036 to M.A.M.P.]; Regional Government of Madrid, RAREGenomics-CM [B2017/BMD-3721 to C.A. and B2017/BMD3721 to M.A.M.P.]; all co-funded with European Regional Development Funds (ERDF) as well as EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [676559]; University Chair UAM-IIS-FJD of Genomic Medicine and the Ramon Areces Foundation also supported this work. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R].
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses

  • Chacón-Solano, Esteban|||0000-0002-5697-7625
  • León Canseco, Carlos
  • Díaz, F.
  • García-García, Francisco
  • García, Montserrat|||0000-0002-3437-3185
  • Escámez, M.J.|||0000-0002-5434-1885
  • Guerrero-Aspizua, Sara
  • Conti, C.J.
  • Mencía, None
  • Martínez Santamaría, Lucía|||0000-0002-9637-2364
  • Llames, Sara|||0000-0001-5456-1389
  • Pévida, M.
  • Carbonell-Caballero, J.
  • Puig-Butille, Joan Anton
  • Maseda Pedrero, Rocío
  • Puig, Susana|||0000-0003-1337-9745
  • Lucas, Raúl de
  • Baselga Torres, Eulàlia|||0000-0003-1086-8439
  • Larcher, Fernando
  • Dopazo, Joaquín|||0000-0003-3318-120X
  • del Río, Marcela
Background: Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders. Objectives: To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB, KS and XPC. Methods: We conducted RNA-Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies. Results: Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (ECM) proteins. Western blot and immunofluorescence in situ analyses validated the RNA-Seq data. In addition, enzyme-linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB. Conclusions: Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury-sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB, XPC and KS. What's already known about this topic?. Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three genodermatoses with high predisposition to cancer development. Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders. What does this study add?. We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix-synthetic capacity. This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor-β signalling activation and oxidative state imbalance. What is the translational message?. This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention. It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.